Angiography News and Research

RSS

CHF associated with reduced patency after peripheral endovascular intervention

Congestive heart failure (CHF) is a highly prevalent comorbidity among patients with symptomatic peripheral arterial disease. The effect of CHF on the procedural success of endovascular treatment, however, remains unknown.

25 Jan 2012

Traditional autopsy is still the gold standard in determining cause of death

TV crime shows like Bones and CSI are quick to explain each death by showing highly detailed scans and video images of victims' insides. Traditional autopsies, if shown at all, are at best in supporting roles to the high-tech equipment, and usually gloss over the sometimes physically grueling tasks of sawing through skin and bone.

17 Jan 2012

Ortho Kinematics' KineGraph Vertebral Motion Analyzer receives FDA 510(k) clearance

Ortho Kinematics‚ a private company focused on revolutionizing spine motion analysis, announced receiving 510(k) clearance from the U.S. Food and Drug Administration for the KineGraph VMA (Vertebral Motion Analyzer) system. The KineGraph VMA system is designed to improve a test routinely prescribed by spine surgeons—the flexion/extension x-ray.

11 Jan 2012

Grief and heart attacks linked: Study

Researchers have found that grief might actually break ones heart. A new study shows that people grieving the death of a close loved one could have a heart attack risk that is 20 times higher than normal.

10 Jan 2012

Surgeon volume and in-hospital mortality for open AAA repair

Researchers from Southwestern Texas University's Division of Vascular and Endovascular Surgery and the Veterans Medical Center, both in Dallas, have reported that composite surgeon (overall) volume rather than operation-specific (annual) surgeon volume is a key determinant of in-hospital mortality for elective open abdominal aortic aneurysm surgery.

21 Dec 2011

Study reveals classification scheme for treatment of blunt aortic injury

New research at the University of Washington's (UW) Harborview Medical Center in Seattle reveals a classification scheme for the treatment of blunt aortic injury.

1 Dec 2011

Toshiba announces new functional-based clinical applications

Toshiba America Medical Systems, Inc. announces new functional-based clinical applications - Dual Energy and Myocardial Perfusion (both works-in-progress), as well as Body Perfusion - for its Aquilion CT systems.

1 Dec 2011

Duplex ultrasound screening can detect high rate of LDVT's in critically ill trauma patients

A study published in the September 2011 issue of the Journal of Vascular Surgery®, the official publication of the Society for Vascular Surgery®, reports that a high rate of lower deep vein thromboses (LDVT's) in critically ill trauma cases can be detected through duplex ultrasound screening (DUS).

1 Dec 2011

Coronary CTA reveals different heart attack risk scenarios for men and women

Findings on coronary CT angiography (CTA), a noninvasive test to assess the coronary arteries for blockages, show different risk scenarios for men and women, according to a study presented today at the Radiological Society of North America.

30 Nov 2011

3-D modeling combined with medical imaging provides new hope for serious facial injuries

By combining conventional medical imaging with some of the same 3-D modeling techniques used in Hollywood blockbusters, researchers are offering new hope to victims of serious facial injuries. Results of a new study on human face transplantation, led by Darren M. Smith, M.D., plastic surgery resident at the University of Pittsburgh Medical Center (UPMC), were presented today at the annual meeting of the Radiological Society of North America (RSNA).

28 Nov 2011

Toshiba showcases Vantage Titan 3T MR whole-body imager at RSNA 2011

Designed to eliminate the patient compliance challenges and poor whole-body images associated with 3T MR imaging, Toshiba has developed the Vantage Titan™ 3T MR. The new system is showcased at this year's Radiological Society of North America (RSNA) annual meeting in Chicago, Nov. 27 - Dec. 2, 2011.

28 Nov 2011

Ziehm Imaging to highlight Vision RFD hybrid at RSNA 2011

Ziehm Imaging, leading developer, manufacturer and supplier of mobile C-arms, presents its innovative, award-winning product portfolio at RSNA 2011. Latest market analyst reports (GIA[1]) predict substantial growth for the fluoroscopy and mobile C-arm market segments that will be substantially driven by the growing number of minimally invasive procedures.

25 Nov 2011

Philips launches Veradius Neo mobile C-arm with flat detector for orthopedic procedures

Royal Philips Electronics today introduced the Philips Veradius Neo mobile C-arm with flat detector to allow surgeons to more easily and precisely handle challenging patients and procedures.

From Philips Healthcare 24 Nov 2011

New CAD test associated with higher rates of cardiac procedures, health-care spending

A new, noninvasive diagnostic test for coronary artery disease is associated with a higher rate of subsequent invasive cardiac procedures and higher health-care spending. That's according to an observational study of Medicare recipients conducted by researchers at the Stanford University School of Medicine.

16 Nov 2011

Blood-based gene expression test more effective in ruling out obstructive CAD

A blood-based gene expression test was found to be more effective for ruling out obstructive coronary artery disease in stable symptomatic patients than myocardial perfusion imaging (MPI), a common test that uses a radioactive agent to evaluate the blood flow and function of the heart.

16 Nov 2011

Positive long-term data from Abbott's ABSORB drug eluting BVS trial on CAD

Abbott today announced positive long-term data from the two-stage ABSORB trial, which is evaluating the ABSORB drug eluting bioresorbable vascular scaffold (BVS) for the treatment of coronary artery disease.

15 Nov 2011

Elixir Medical announces initiation of DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System study

Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced enrollment initiation for a 120-patient, international pivotal clinical study to evaluate the safety and efficacy of the DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System designed to resorb in the body within 1 to 2 years after implantation and return the patients' coronary vessel to de novo state.

11 Nov 2011

Treatments can help most HCM patients

Most of the 600,000 Americans with hypertrophic cardiomyopathy (HCM) -- a genetic heart muscle disease -- can live normal life spans, according to the first science-based guideline for diagnosing and treating this disorder.

9 Nov 2011

Micell announces preliminary data from MiStent Sirolimus DES clinical study

Micell Technologies, Inc. today announced the release of preliminary data from the first-in-human clinical study of the MiStent Sirolimus Drug Eluting Coronary Stent System (MiStent DES), a thin-strut drug-eluting stent distinguished by a rapid-absorbing drug/polymer coating designed for controlled drug release.

9 Nov 2011

Gilead, CRF commence ranolazine Phase 3 clinical trial for chronic stable angina in post-PCI setting

Gilead Sciences, Inc. and the Cardiovascular Research Foundation (CRF) today announced the initiation of RIVER-PCI (Ranolazine for Incomplete VEssel Revascularization post-PCI), a Phase 3 clinical trial evaluating the utility of ranolazine to prevent major adverse cardiovascular events (MACE) in patients with a history of chronic angina who have incomplete revascularization following percutaneous coronary intervention (PCI).

7 Nov 2011